Aβ aggregation-IN-4
Aβ aggregation-IN-4 can alleviate the neurotoxicity of amyloid-β protein (Aβ) and significantly reduce the level of oligomeric complexes of Aβ (Aβ-OCs). Aβ aggregation-IN-4 does not decrease the level of amyloid-β protein (Aβ). Aβ aggregation-IN-4 attenuates Aβ oligomerization and prevents oligomer-induced death of primary cortical neurons. Aβ aggregation-IN-4 can be used for the study of Alzheimer’s disease (AD).
For research use only. We do not sell to patients.
- CAS No.: 603113-07-1
- Formula: C21H23N5O3
- Molecular Weight:393.44
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Aβ aggregation-IN-4 (0-2 μM, 24-48 hours) can protect MC65 cells and reduce the level of intracellular Aβ oligomers in MC65 cells in a dose-dependent manner (EC50=0.15 μM)[1].
Aβ aggregation-IN-4 (0-14 hours) is a cell-permeable compound. [14C]Amyloid-β-IN-4 can reach a saturated concentration in MC65 cells within 2 hours and can enter the cells rapidly[1].
The binding affinities (Kd) of Aβ aggregation-IN-4 to Aβ40 and Aβ42 are 5.05 nM and 269 nM, respectively[1].
Aβ aggregation-IN-4 (10 μM, 24 hours) can significantly reduce the density of Aβ40 and Aβ42 oligomers[1].
Aβ aggregation-IN-4 (50 nM, 48 hours) can block the neurotoxicity of extracellular Aβ oligomers in primary neuron cultures of the neonatal mouse cortex[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Primary cultures of cortical neurons from newborn mice
-
Concentration:50 nM
-
Incubation Time:48 h
-
Result:Blocked the neurotoxicity of extracellular Aβ oligomers in primary cultures of cortical neurons from newborn mice.
Chemical Information
-
CAS No. 603113-07-1
-
Molecular Weight 393.44
-
Formula C21H23N5O3
-
SMILES
[H][C@]12C[C@H](CCC1=CC3=C(O2)C=C(OC3=O)C)[C@@H](CN4C=NC(N)=C5C4=NC=N5)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Neurotoxicity Study
This protocol assesses in vitro neurotoxicity by combining neuronal viability, mitochondrial/metabolic activity, neurite outgrowth, and optional neuronal network function readouts. Calcein-AM or resazurin/PrestoBlue readouts estimate viable or metabolically active cells; βIII-tubulin immunofluorescence detects neuronal morphology and neurite networks; TMRE detects mitochondrial membrane potential; and MEA recordings detect functional changes in neuronal network activity.
-
Primary Embryonic Cortical Neuron Culture
Primary embryonic cortical neuron culture isolates cortical tissue from prenatal rodents, dissociates it into single cells, and maintains neurons in vitro so that neurite extension, neuronal marker expression, synapse formation, survival, and treatment responses can be examined outside the intact brain.
-
Amyloid: Congo Red Amyloid Staining
Congo red amyloid staining is a histochemical method used to detect extracellular amyloid deposits in tissue sections based on the affinity of Congo red dye for β-pleated sheet-rich protein aggregates. When bound to amyloid, Congo red produces characteristic apple-green birefringence under polarized light microscopy, which is widely regarded as a diagnostic feature of amyloid deposition in histopathology. The diagnostic principle relies on the combination of dye binding (congophilia) and optical anisotropy under polarized illumination, which distinguishes amyloid from most non-amyloid eosinophilic extracellular deposits in routine histological evaluation. Amyloid identification by Congo red staining remains a cornerstone in diagnostic pathology despite the availability of adjunct methods such as immunohistochemistry and mass spectrometry, particularly because of its ability to localize deposits directly within tissue architecture. The specificity of Congo red-positive deposits is incre
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)